|Awarded On||November 19, 2015|
|Title||Maximizing opportunities for HPV vaccination in the Golden Triangle|
|Award Mechanism||Evidence-Based Prevention Programs and Services|
|Institution/Organization||The University of Texas Medical Branch at Galveston|
|Principal Investigator/Program Director||Abbey Berenson|
|Cancer Sites||Cervix Uteri, Head and Neck, Penis, Vagina, Vulva|
In spite of its ability to prevent cancer and strong recommendations for vaccination from the Centers for Disease Control and Prevention, the HPV vaccine remains underutilized in the US. Only 57 percent and 35 percent of girls and boys 13-17 years old, respectively, have initiated the 3-dose series. Among 18-26 year olds, only 35 percent of women and 2 percent of men have received at least one 1 dose. Completion rates are even lower in both groups.
Vaccination rates are particularly low in Texas’ Golden Triangle (Jefferson and Orange Counties); our surveys have found that only 14 percent of 11-26 year olds have received at least 1 dose of the vaccine. This is concerning given that resi...